---
title: "A Novel 2-Metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT."
collection: publications
permalink: https://www.mdpi.com/2072-6694/14/12/3031
excerpt: ''
date: 2022-06-20
venue: 'Cancers'
paperurl: 'https://www.mdpi.com/2072-6694/14/12/3031'
---
[Download paper here](https://www.mdpi.com/2072-6694/14/12/3031)